Overcoming inhibitors in myelin to promote axonal regeneration.
about
Nogo goes in the pure water: solution structure of Nogo-60 and design of the structured and buffer-soluble Nogo-54 for enhancing CNS regenerationOligodendrocyte precursor cells differentially expressing Nogo-A but not MAG are more permissive to neurite outgrowth than mature oligodendrocytesNeurite outgrowth of mature retinal ganglion cells and PC12 cells requires activity of CK1δ and CK1εHDAC6 is a target for protection and regeneration following injury in the nervous systemPhosphodiesterase type 4 inhibitor rolipram improves survival of spiral ganglion neurons in vitroSpontaneous association of glial cells with regrowing neurites in mixed cultures of dissociated spiral ganglia.Developmental regulation of sensory axon regeneration in the absence of growth conesMicroRNA miR-133b is essential for functional recovery after spinal cord injury in adult zebrafishA chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regeneration.PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.Myelin recovery in multiple sclerosis: the challenge of remyelinationAxonal transport proteomics reveals mobilization of translation machinery to the lesion site in injured sciatic nerve.Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitisRegulation of intrinsic axon growth ability at retinal ganglion cell growth conesThe expression patterns of Nogo-A, myelin associated glycoprotein and oligodendrocyte myelin glycoprotein in the retina after ocular hypertension: the expression of myelin proteins in the retina in glaucoma.Differential expression of proteins in monozygotic twins with discordance of infantile esotropic phenotypes.Pathological changes in the white matter after spinal contusion injury in the ratNeurotrophin treatment to promote regeneration after traumatic CNS injury.LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis.The role of well-defined patterned substrata on the regeneration of DRG neuron pathfinding and integrin expression dynamics using chondroitin sulfate proteoglycans.A chemical genetic approach identifies piperazine antipsychotics as promoters of CNS neurite growth on inhibitory substrates.Effect of XingPiJieYu decoction on spatial learning and memory and cAMP-PKA-CREB-BDNF pathway in rat model of depression through chronic unpredictable stressRegeneration following spinal cord injury, from experimental models to humans: where are we?Effect of Y-27632 on the cultured retinal neurocytes of rats.Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.Regulation of axonal regeneration following the central nervous system injury in adult mammalian.Mitochondrial Dynamics in Retinal Ganglion Cell Axon Regeneration and Growth Cone Guidance.Molecular targets for axon regeneration: focus on the intrinsic pathways.Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients.Chemical priming for spinal cord injury: a review of the literature. Part I-factors involved.Role of myelin-associated inhibitors in axonal repair after spinal cord injury.Integrated microfluidics platforms for investigating injury and regeneration of CNS axons.Advances in microfluidics-based experimental methods for neuroscience research.Designing drugs that encourage spinal cord injury healing.Potentially neuroprotective gene modulation in an in vitro model of mild traumatic brain injury.Neuropathological Characteristics of Brachial Plexus Avulsion Injury With and Without Concomitant Spinal Cord Injury.Nogo-A expression after focal ischemic stroke in the adult ratExercise decreases myelin-associated glycoprotein expression in the spinal cord and positively modulates neuronal growth.Developmental expression of the oligodendrocyte myelin glycoprotein in the mouse telencephalon.
P2860
Q24647661-13567279-57DE-4067-A419-E04FBF14EE17Q28564783-2CEF085C-A691-4030-8078-B471C5BBB67DQ28573292-BB400B35-5F96-418D-81EA-2C87A10396F1Q28575078-BAC953D2-F7D6-49CB-AC77-282E0C92563EQ30441402-2AB44D68-6A1B-4516-99DD-ECB6BFFDF49EQ30481055-7906F950-6170-4EED-B25B-1FE813B46523Q30486805-46BEF203-78B7-477A-ADE8-4C3200452077Q30500389-04BCC97F-6A5B-4D2D-BFC1-80EFAAD972FCQ33548229-A3B5E52B-11C9-4129-B427-DE6AC852372AQ33610127-57B17333-1460-48A6-AE90-92A30A45CDF7Q33772195-4054C41F-E3E9-49CB-9F79-81C89D280C3FQ33855022-9EC19C48-69EC-44F2-8ADA-3A2EAEEDCAA3Q33862545-2D3760B7-A6B6-4911-B065-0C2116B90098Q33915929-435EE2AE-CC4E-450F-97D8-C1126AA479D7Q33924046-33BC28A5-4095-4ABB-9079-FD56696D01ADQ33954290-24295DA1-B901-4DB7-8257-2E73D504AE8FQ34405218-430E2E0C-AE3E-48DD-BFB9-A78E69AB55EEQ34547330-818426F8-6341-4788-85ED-1871B4B5C607Q34662718-93CCC86F-D16A-4ECC-8AEC-A7B4D7DAE459Q35067696-60212338-BA00-460F-B198-D937FFFD630FQ35869761-668B504E-7ABF-4AC8-B119-2DBF02AD2404Q36059047-CA588349-F7DF-4754-8368-FDFFE847EA71Q36259063-E42C24B5-B3D4-4C10-B3C0-BF86A75B994FQ36481046-4D3E2E80-5534-4712-8C90-16717AB16171Q36632413-2D763DE9-C3B8-473C-B176-F9D57C1D14CDQ37139712-E067AFE0-A1AD-4D70-969C-650F2DBF18DEQ37335884-508F3989-5122-4719-8AC8-4BADFC9D1249Q37625339-D8E2D603-A3C4-4A35-ADE6-C18931BE248DQ37634551-E443506C-AB25-4C93-835E-EBD88F3F05BDQ37665009-F02A28B0-74ED-4605-BD3E-6914A3B88B8BQ37822292-0A443A27-42C4-4944-8C65-FF321CD5B6E6Q37877302-FADA581D-80EF-4847-AC3F-DFB3D741C27AQ37981097-AC5A765D-E0FF-4E77-8F05-493AE7A9497DQ38073067-AE4786BF-3BBB-45ED-A716-2BDEC3FE4755Q38234093-4B6E951A-8C90-4953-93F7-E1D42D19CEFCQ38319232-2B2C5D9C-5D99-4DDC-9F4B-6739D77E5042Q40207513-BF8892BF-CB04-43AF-97C4-49D73554E4C6Q41828817-331FC030-CD6D-4A85-9C77-778C3477F4D3Q42152635-507BA9CA-12A8-4C5A-ACB7-94174FEA1F2FQ42735632-4B5A1DBE-BAC4-47EA-BCC9-34FAF5A2DDA8
P2860
Overcoming inhibitors in myelin to promote axonal regeneration.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Overcoming inhibitors in myelin to promote axonal regeneration.
@ast
Overcoming inhibitors in myelin to promote axonal regeneration.
@en
Overcoming inhibitors in myelin to promote axonal regeneration.
@nl
type
label
Overcoming inhibitors in myelin to promote axonal regeneration.
@ast
Overcoming inhibitors in myelin to promote axonal regeneration.
@en
Overcoming inhibitors in myelin to promote axonal regeneration.
@nl
prefLabel
Overcoming inhibitors in myelin to promote axonal regeneration.
@ast
Overcoming inhibitors in myelin to promote axonal regeneration.
@en
Overcoming inhibitors in myelin to promote axonal regeneration.
@nl
P1476
Overcoming inhibitors in myelin to promote axonal regeneration.
@en
P2093
Marco Domeniconi
Marie T Filbin
P356
10.1016/J.JNS.2005.03.023
P577
2005-04-20T00:00:00Z